Header Ads



Seo Services
Home Latest News Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

September 15, 2020
The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.

from Latest News https://ift.tt/3keaZU6
Tags :

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.